非鎮静性抗ヒスタミンのリスク

Identification of the Language Network from Resting-State fMRI in Patients with Brain Tumors: How Accurate Are Experts?

AJNR. American journal of neuroradiology·2023

Adverse drug reaction reporting in Europe: some problems of comparison.

The International journal of risk & safety in medicine·2013

Correlation between plasma quinidine and cardiac effect.

British journal of clinical pharmacology·2012

Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.

Inflammatory bowel diseases·2009

International monitoring of adverse health effects associated with herbal medicines.

Pharmacoepidemiology and drug safety·2008

The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.

Fundamental & clinical pharmacology·2008

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.

Journal of Asian natural products research·2026

In Vitro Effects of Centaurea ovina (Roudbari Cornflower) Aqueous and Ethanolic Extracts on Staphylococcus saprophyticus: Growth Inhibition, Antibiofilm Activity, and Reduced ureC/uafA Transcripts.

International journal of microbiology·2026

Sperm-disrupting activity of a root bark fraction of Flueggea virosa (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

Frontiers in pharmacology·2026

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Frontiers in behavioral neuroscience·2026

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Expert opinion on pharmacotherapy·2026

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

Endocrine, metabolic & immune disorders drug targets·2026

関連する実験動画

非鎮静性抗ヒスタミンのリスク

関連する概念動画

Identification of the Language Network from Resting-State fMRI in Patients with Brain Tumors: How Accurate Are Experts?

Adverse drug reaction reporting in Europe: some problems of comparison.

Correlation between plasma quinidine and cardiac effect.

Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.

International monitoring of adverse health effects associated with herbal medicines.

The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus <i>Penicillium herquei</i>.

In Vitro Effects of <i>Centaurea ovina</i> (Roudbari Cornflower) Aqueous and Ethanolic Extracts on <i>Staphylococcus saprophyticus</i>: Growth Inhibition, Antibiofilm Activity, and Reduced <i>ureC</i>/<i>uafA</i> Transcripts.

Sperm-disrupting activity of a root bark fraction of <i>Flueggea virosa</i> (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

関連する実験動画

非鎮静性抗ヒスタミンのリスク

関連する概念動画

関連記事